Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

Incyte AD November 2023

What were the notable results of the TRuE-AD clinical trials for topical ruxolitinib?

Atopic Dermatitis

The results from the clinical trials with topical rexalidinib were really interesting. First of all, there were two clinical trials that were done. Different patients, different investigators, different places. Yet the data looks almost like mirror images. They look very, very similar. We see a rapid improvement even at the first time point we see separation from the vehicle, and that improvement can continues over the course of the study. And overall, about 50% of patients got to clear or almost clear using this drug as monotherapy. We also found that it was well tolerated and very few patients noticed stinging or burning.

What were the notable results of the TRuE-AD clinical trials for topical ruxolitinib?

Related CME